Search for Clinical Trial Results

Sponsored By

Multiple Endocrine Neoplasia Type 1 - 9 Studies Found

Status Study
Active, not recruiting Study Name: Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
Condition:
  • Multiple Endocrine Neoplasia Type 1
  • Pancreatic Neuroendocrine C
    Date: 2014-03-28
    Interventions:
    • Radiation: Computed Tomography Perfusion Imaging

Not yet recruiting Study Name: Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment
Condition: Pancreatic Neuroendocrine Tumors in MEN1
Date: 2016-03-02
Interventions: Drug: Somatostatin-Analog A long-acting somatostatin-analog will be applied.
Recruiting Study Name: Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Condition: Multiple Endocrine Neoplasia
Date: 2017-02-07
Recruiting Study Name: Genetic Evaluation of Families With Endocrine Cancers
Condition:
  • Pancreatic Cancer
  • Thymic Cancer
  • Parathyroid Disease
    • <
    Date: 2013-02-15
    Interventions: Genetic: Blood draw Blood draw
Completed Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
Condition:
  • Gastrin-Producing Neuroendocrine Tumor
  • Lung Carcinoid Tumor
  • Other: Laboratory Biomarker Analysis

Not yet recruiting Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Condition:
  • Functional Pancreatic Neuroendocrine Tumor
  • Malignant Somatostatinoma
  • Drug: Capecitabine Given PO
Recruiting Study Name: Familial Investigations of Childhood Cancer Predisposition
Condition:
  • Acute Leukemia
  • Adenomatous Polyposis
  • Adrenocortical Carcin
    Date: 2017-02-08
Recruiting Study Name: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)
Condition:
  • Genetic Mutation
  • MEN1

Date: 2017-02-02
Interventions:
  • Other: Chart Review Database r
Completed Study Name: Capecitabine and Temozolomide for Neuroendocrine Cancers
Condition: Neuroendocrine Tumors
Date: 2009-03-23
Interventions:
  • Drug: Capecitabine